German Pavilion at
BioJapan 2019
9 – 11 October 2019 – Yokohama, Japan
News & Innovations
News and innovations published by German exhibitors
Comprehensive services
Full dossiers for health technology assessments in Europe European core values dossiers Market analysis Real-world analysis and analysis of care provision Market access and pricing strategies Clinical trials
Exhibitor: IGES Institut GmbH
Further reading12th BioVaria brings academia and industry together
13 May 2019, Munich, Germany – The 12th BioVaria welcomed over 250 life-science innovators to Munich, including biopharma executives, investors, academic inventors, entrepreneurs and technology transfer experts. There were 67 peer-selected licensing opportunities on offer, originating from as many research…
Exhibitor: Ascenion GmbH
Further readingAscenion supports collaboration agreement between HZI / HIPS and GARDP
The Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), a location of the Helmholtz Centre for Infection Research (HZI), teams up with the Global Antibiotic Research and Development Partnership (GARDP) to discover novel antibiotics. Ascenion, the HZI’s technology transfer partner, supported the…
Exhibitor: Ascenion GmbH
Further readingOMEICOS starts Phase II Trial in Atrial Fibrillation
Ascenion’s portfolio company OMEICOS dosed a first patient in a Phase II clinical trial for its lead program OMT-28. The placebo-controlled, double-blind, randomized PROMISE-AF study will evaluate the efficacy and safety of the candidate in patients with persistent atrial fibrillation…
Exhibitor: Ascenion GmbH
Further readingWe are looking for?
boneArtis is currently looking for dentists throughout the world, who wish to participate in an on-going scientific study, based upon the unique approach of our bone void fillers, for dental augmentation and bone reconstruction. boneArtis is looking for distributors and…
Exhibitor: boneArtis AG
Further readingSDI® Surgical Diamond Instruments
Are you still replacing or already resurfacing? boneArtis AG boneArtis is the only company reconstructing joints instead of replacing joints using the diamond technology. Ultraprecise diamond guided perfection in surgery. boneArtis AG understands to be the Company (Cy) for diamond…
Exhibitor: boneArtis AG
Further readingThe Ceraball®Principle is en marche. Future of Dental Augmentation.
The most Intelligent Solution to Reconstruct Cancellous Bone. boneArtis® personifies a story written by applied research during daily surgical work, starting in the basement and garage. Based on that history the bone forming elements were detected changing fundamentally the world of surgical interventions and…
Exhibitor: boneArtis AG
Further readingMaillard Reaction Products (MRPs) - Markers for the Quality of Food, used in Cosmetics, Biochemistry, and Pharma Industry
Proteins contained in meat and other comestible goods are usually rich in the amino acids arginine and lysine. Their side chain functional groups react with reducing carbohydrates such as glucose to form Amadori reaction products. These characteristic intermediates decompose particularly…
Exhibitor: Iris Biotech GmbH
Further readingHydrolysis-Stable Mimics of Phosphorylated Amino Acids (Ser, Thr and Tyr)
Phosphorylation of serine, threonine and tyrosine is counted among the most important posttranslational modifications that occur in organisms. Therefore, the preparation of synthetic phosphorylated peptides is of significant interest for researchers. However, those synthetic efforts are frequently hampered by the…
Exhibitor: Iris Biotech GmbH
Further readingXylan, Pharma Grade - Key Starting Material for Pentosan Polysulfate
Xylan (CAS 9014-63-5) is a hemicelluloses that is found in plant cell walls, some algae, and hardwoods. Xylan, particularly from German form beechwood is the key starting material for Pentosan polysulfate (PPS, (1->4)-β-Xylan 2,3-bis(hydrogen sulfate) a drug for the relief…
Exhibitor: Iris Biotech GmbH
Further readingDigiMed Bayern for the Medicine of the Future
P4 medicine (predictive, preventive, personalized, participatory) is one of the world's most promising developments for improved, holistic and efficient health care. DigiMed Bayern's goal is to guide Bavaria into this medicine of the future. BioM’s lighthouse P4-medicine project DigiMed Bayern…
Exhibitor: BioM Biotech Cluster Development
Further reading